New plant inaugurated at Himatnagar site
Bayer strengthens its manufacturing footprint in Gujarat
Ahmedabad, January 25, 2019: Today, Bayer CropScience Limited inaugurated a new plant in its Himatnagar site in Gujarat. The plant is equipped with advanced technology for manufacture of Suspension Concentrates. These eco-friendly formulations will be used in Bayer’s Crop Protection & Environmental Science products.
Till date, Bayer has invested over INR 1 billion (100 Crores) in the Himatnagar site.
“Himatnagar is a key production site for Bayer in India, catering to local consumption as well as exports. This new plant will enable us to expand our production capacity by 25 percent and will support the growth of our Crop Protection and Environmental Science business in South Asia. It will also help us deliver products faster to our customers, while ensuring the highest standards of quality,” said D. Narain, Senior Bayer Representative, South Asia.
The Himatnagar site commenced operations in 1991 with the production of Folidol dust formulations. Over the years the site underwent significant changes with the introduction of new generation formulations like Suspension Concentrates (SC), Water dispersible granules (WG) and Oil dispersion (OD). As of today, the site is a major exporter of WG Products to various regions across the globe including Brazil and Europe. It has five state-of-the-art formulation plants spread over 4.3 acres and employs 104 full time employees.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.com.
Crop Science Communications, Bayer Group in India
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.